JN Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Neurophysiol 81: 2875-2883, 1999;
0022-3077/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamada, K.
Right arrow Articles by Gallagher, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamada, K.
Right arrow Articles by Gallagher, J. P.

The Journal of Neurophysiology Vol. 81 No. 6 June 1999, pp. 2875-2883
Copyright ©1999 by the American Physiological Society

Different Subtypes of GABAB Receptors Are Present at Pre- and Postsynaptic Sites Within the Rat Dorsolateral Septal Nucleus

Kei Yamada, Baojian Yu, and Joel P. Gallagher

Department of Pharmacology and Toxicology, University of Texas Medical Branch at Galveston, Galveston, Texas 77555-1031

Yamada, Kei, Baojian Yu, and Joel P. Gallagher. Different Subtypes of GABAB Receptors Are Present at Pre- and Postsynaptic Sites Within the Rat Dorsolateral Septal Nucleus. J. Neurophysiol. 81: 2875-2883, 1999.Different subtypes of GABAB receptors are present at pre- and postsynaptic sites within the rat dorsolateral septal nucleus. GABAB receptor activation modulates neuronal activity mediated by multiple CNS transmitters and can occur at pre- and postsynaptic sites. In low concentrations, baclofen acts presynaptically to diminish transmitter release via both hetero- and autoreceptors, whereas at increasing concentrations, the same compound alters postsynaptic membrane excitability by inducing a membrane hyperpolarization.

We have utilized electrophysiological techniques in vitro to focus on the possibility that pharmacologically different subtypes of GABAB receptors are present on presynaptic sites of glutamatergic terminals when compared with GABAB receptors on postsynaptic sites within the dorsolateral septal nucleus (DLSN). The glutamatergic terminal within the DLSN originates from a pyramidal cell body located within the hippocampus and most likely terminates on a GABAergic neuron from which recordings were made. Whole cell patch voltage-clamp methods were employed to record pharmacologically isolated excitatory postsynaptic currents (EPSCs) from DLSN neurons as an index of glutamatergic transmission. Using a modified internal pipette solution containing QX-314 and in which CsGluconate and GDPbeta S replaced Kgluconate and GTP, respectively, we recorded isolated monosynaptic EPSCs. The GABAA receptor antagonists bicuculline and picrotoxin were included in the external standard superfusion solution. Application of the GABAB receptor agonists, (±)-baclofen, CGP44533, and CGP35024 (10 nM to 10 µM) depressed glutamate-mediated EPSCs in a concentration-dependent manner. With the use of this combination of solutions, CGP44533 did not produce postsynaptic membrane property changes. Under these conditions, both (±)-baclofen and CGP35024 still induced increases of postsynaptic membrane conductance associated with an outward current. The GABAB receptor antagonist CGP55845A (1 µM) blocked the presynaptic CGP44533-mediated depressant effects of EPSCs, whereas CGP35348 (100 µM) or barium (2 mM) was ineffective. Futhermore, both CGP35348 (100 µM) and CGP55845A (1 µM) were effective in blocking the postsynaptic conductance changes associated with baclofen and CGP35024, whereas barium was ineffective.

Our results demonstrate a distinct pharmacology for GABAB agonists acting at putative subtypes of GABAB receptors located on presynaptic sites of a glutamatergic terminal versus GABAB receptors on postsynaptic sites of a DLSN neuron. Furthermore, our results also suggest a different pharmacology and/or coupling of a GABAB receptor to different effectors at postsynaptic sites within the DLSN. Thus there may be three or more pharmacologically distinct GABAB receptors or receptor complexes associated with DLSN neurons: at least one pre- and two postsynaptic. If this distinct pharmacology and GABAB receptor distribution also extends to other CNS structures, such differences could provide development of selective drugs to act at these multiple sites.




This article has been cited by other articles:


Home page
 J. Neurosci.Home page
L. Orozco-Cabal, J. Liu, S. Pollandt, K. Schmidt, P. Shinnick-Gallagher, and J. P. Gallagher
Dopamine and Corticotropin-Releasing Factor Synergistically Alter Basolateral Amygdala-to-Medial Prefrontal Cortex Synaptic Transmission: Functional Switch after Chronic Cocaine Administration
J. Neurosci., January 9, 2008; 28(2): 529 - 542.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
W. Koek, W. Chen, S. L. Mercer, A. Coop, and C. P. France
Discriminative Stimulus Effects of {gamma}-Hydroxybutyrate: Role of Training Dose
J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 409 - 417.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
Y.-W. Cheng, M.-C. Ku, C.-M. Ho, C.-Y. Chai, and C.-K. Su
GABAB-receptor-mediated suppression of sympathetic outflow from the spinal cord of neonatal rats
J Appl Physiol, November 1, 2005; 99(5): 1658 - 1667.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
M. Kolaj, D. Bai, and L. P. Renaud
GABAB Receptor Modulation of Rapid Inhibitory and Excitatory Neurotransmission From Subfornical Organ and Other Afferents to Median Preoptic Nucleus Neurons
J Neurophysiol, July 1, 2004; 92(1): 111 - 122.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
B. Bettler, K. Kaupmann, J. Mosbacher, and M. Gassmann
Molecular Structure and Physiological Functions of GABAB Receptors
Physiol Rev, July 1, 2004; 84(3): 835 - 867.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
L. P. Carter, A. W. Unzeitig, H. Wu, W. Chen, A. Coop, W. Koek, and C. P. France
The Discriminative Stimulus Effects of {gamma}-Hydroxybutyrate and Related Compounds in Rats Discriminating Baclofen or Diazepam: The Role of GABAB and GABAA Receptors
J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 540 - 547.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. Motalli, M. D'Antuono, J. Louvel, I. Kurcewicz, G. D'Arcangelo, V. Tancredi, M. Manfredi, R. Pumain, and M. Avoli
Epileptiform Synchronization and GABAB Receptor Antagonism in the Juvenile Rat Hippocampus
J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 1102 - 1113.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
H. Hasuo, T. Matsuoka, and T. Akasu
Activation of Presynaptic 5-Hydroxytryptamine 2A Receptors Facilitates Excitatory Synaptic Transmission via Protein Kinase C in the Dorsolateral Septal Nucleus
J. Neurosci., September 1, 2002; 22(17): 7509 - 7517.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
N. G. Bowery, B. Bettler, W. Froestl, J. P. Gallagher, F. Marshall, M. Raiteri, T. I. Bonner, and S. J. Enna
International Union of Pharmacology. XXXIII. Mammalian gamma -Aminobutyric AcidB Receptors: Structure and Function
Pharmacol. Rev., June 1, 2002; 54(2): 247 - 264.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
P. Mann-Metzer and Y. Yarom
Pre- and Postsynaptic Inhibition Mediated by GABAB Receptors in Cerebellar Inhibitory Interneurons
J Neurophysiol, January 1, 2002; 87(1): 183 - 190.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Interv.Home page
S. J. Enna
A GABAB Mystery: The Search for Pharmacologically Distinct GABAB Receptors
Mol. Interv., October 1, 2001; 1(4): 208 - 218.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. A. Blackshaw
Receptors and Transmission in the Brain-Gut Axis: Potential for Novel Therapies: IV. GABAB receptors in the brain-gastroesophageal axis
Am J Physiol Gastrointest Liver Physiol, August 1, 2001; 281(2): G311 - G315.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L.-N. Cui, E. Coderre, and L. P. Renaud
GABAB presynaptically modulates suprachiasmatic input to hypothalamic paraventricular magnocellular neurons
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2000; 278(5): R1210 - R1216.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
W. Zhou, C. Arrabit, S. Choe, and P. A. Slesinger
Mechanism underlying bupivacaine inhibition of G protein-gated inwardly rectifying K+ channels
PNAS, May 22, 2001; 98(11): 6482 - 6487.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online